Environmental Pollution, Hormonal Disruption, and Merkel Cell Carcinoma — Current Evidence and What We Still Need in 2026
Merkel cell carcinoma (MCC) is a rare, highly aggressive cutaneous neuroendocrine tumor whose incidence has been increasing internationally. Two dominant etiologic pathways are recognized: (1) Merkel cell polyomavirus (MCPyV)‑positive tumors driven by viral integration and expression of viral oncoproteins, and (2) MCPyV‑negative tumors driven largely by ultraviolet (UV)‑induced DNA damage and a high mutational burden. Immunosuppression (iatrogenic, hematologic, or disease‑related) markedly raises MCC risk, particularly for MCPyV‑positive cases.
Biologic plausibility for pollution as a cofactor.
-
Environmental pollutants can influence carcinogenesis by multiple mechanisms that are biologically relevant to MCC:
-
Direct genotoxicity: Polycyclic aromatic hydrocarbons (PAHs) and some other pollutants form DNA adducts and produce mutagenic lesions in skin cells in experimental models,providing a direct mutational mechanism.
-
Oxidative stress and chronic inflammation:Particulate matter (PM2.5) and traffic‑related air pollution induce oxidative damage and inflammation in skin, which can promote mutagenesis and a protumor microenvironment.
-
Immune modulation: A range of pollutants and chemical exposures cause immunotoxicity—impairing innate and adaptive immune function.Because immune surveillance is critical to controlling oncogenic viruses (includingMCPyV) and emerging tumor clones,pollutant driven immune dysfunction is a plausible indirect pathway for increased virus associated cancer risk.
-
Endocrine disruption: Per‑ and polyfluoroalkyl substances (PFAS), phthalates, bisphenol A(BPA), PCBs and other endocrine disrupting chemicals (EDCs) alter hormonal signaling.Hormones affect skin biology and immune responses; in theory, EDC‑mediated hormonal perturbation could alter tumor susceptibility or progression, though direct evidence for this pathway in MCC is lacking.
-
Heavy metals: Arsenic is a well‑established skin carcinogen (primarily causing squamous cell carcinoma) via genotoxic and epi genetic mechanisms; other metals (cadmium, chromium)have carcinogenicity in other tissues and can modulate immune function, offering additional mechanistic plausibility.
What the epidemiology shows (and does not)
-
Strong, replicated evidence implicates MCPyVinfection, UV exposure, aging, and immunosuppression as primary drivers of MCC incidence and prognosis. Registry and molecular studies consistently support these conclusions.
-
Evidence specifically linking environmental pollution or pollutant‑driven hormonal disruption to MCC is sparse to non‑existent.Most pollutant–skin cancer epidemiology focuses on non‑melanoma skin cancers (basal cell and squamous cell carcinoma) or melanoma; several studies and meta‑analyses report modest associations between ambient air pollution (PM2.5, traffic‑related pollutants) and non‑melanoma skin cancer risk, but these analyses are limited by confounding (especiallyUV exposure), exposure misclassification, and heterogeneity.
-
PFAS epidemiology has identified associations with kidney and testicular cancers in heavily exposed cohorts; skin‑cancer associations have not been convincingly demonstrated.
-
Occupational case reports and small series occasionally note prior chemical or dust exposures in MCC patients, but these are anecdotal and underpowered to support causal inference.
-
Because MCPyV‑positive and MCPyV‑negative MCC’s have different pathogenesis, lumped analyses that do not stratify by viral status will likely miss distinct exposure relationships.
Mechanistic gaps and research challenges
-
Rarity and heterogeneity: MCC’s low incidence and the existence of two etiologic pathways(viral vs UV) reduce statistical power and complicate exposure–outcome studies.
-
Exposure assessment: Historical, cumulative,and mixed‑chemical exposures (the “cocktail”problem) are difficult to reconstruct.Environmental litter/soil contact, dermal uptake,inhalation, and dietary routes have differing relevance for each pollutant class.
-
Confounding by UV and immunosuppression:Both are major MCC risk factors and are correlated with demographic and behavioral variables that may also affect pollutant exposure.
-
Mechanistic specificity: Few studies have directly tested whether pollutants promoteMCPyV infection, persistence, or reactivation, or whether they synergize with UV in producing MCC relevant mutations.
Practical interpretation for clinicians, researchers, and public health professionals
-
At present the best evidence supports focusing prevention and surveillance efforts on known risk factors: minimizing excessive UV exposure,identifying and managing immunosuppression where possible, and ensuring early detection and rapid management of suspicious lesions.
-
Environmental pollution remains biologically plausible as an MCC cofactor via genotoxic,immunotoxic, inflammatory, or endocrine pathways, but this remains hypothetical without robust epidemiologic confirmation.
-
From a research and public‑health standpoint,investigating environmental contributions to MCC remains worthwhile given plausible mechanisms and the rising incidence of MCC.
Recommended research priorities
-
Large registry‑linked studies that: a) stratify tumors by MCPyV status; b) link individual level or high resolution environmental exposure data(ambient air pollution, occupational histories,PFAS/EDC biomarkers, heavy metal biomarkers)to cancer registries; and c) adjust for UVexposure, immunosuppression, anddemographic confounders.
-
Mechanistic work testing whether pollutants: a)impair skin immune surveillance or promoteMCPyV persistence/reactivation; b) synergizewith UV to increase mutation burden relevant toMCC; c) exert endocrine effects on skin/progenitor/neuroendocrine cells that alter oncogenic susceptibility.
-
Toxicology of realistic environmental mixtures and dermal exposure models reflecting litter/soil contact.
-
Prospective cohorts in high‑exposure populations with biospecimens for viral and chemical biomarker assays.
Bottom line
Pollutant exposure is a biologically plausible but unproven contributor to MCC risk. The current evidence base strongly supports MCPyV infection, UV exposure, and immunosuppression as primary causes; high‑quality epidemiologic and mechanistic studies are needed to evaluate whether environmental pollutants—through genotoxic, immunomodulatory, or endocrine‑disrupting pathways—meaningfully affect MCC incidence or outcomes.
Refrences
-
Becker JC, Stang A, DeCaprio JA, et al. Merkel cell carcinoma. Nat Rev Dis Primers.2017;3:17077.https://doi.org/10.1038/nrdp.2017.77 PubMed:https://pubmed.ncbi.nlm.nih.gov/29072302PMC:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054450/
-
Tribble JT, Pfeiffer RM, Brownell I, et al. Merkel cell carcinoma and immunosuppression, UVradiation, and Merkel cell polyomavirus. JAMADermatol. 2024;161(1):47–55.https://doi.org/10.1001/jamadermatol.2024.4607PubMed:https://pubmed.ncbi.nlm.nih.gov/39602110
-
Harms PW, Harms KL, Moore PS, et al. The biology and treatment of Merkel cell carcinoma.Nat Rev Clin Oncol. 2018;15:763–776.https://doi.org/10.1038/s41571-018-0103-2PubMed:https://pubmed.ncbi.nlm.nih.gov/30158769PMC:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320644/
-
Olsen CM, Pandeya N, Whiteman DC.International increases in Merkel cell carcinomaincidence rates between 1997 and 2016. J InvestDermatol. 2021;141(11):2596–2601.e1.https://doi.org/10.1016/j.jid.2021.04.007PubMed:https://pubmed.ncbi.nlm.nih.gov/33816939
-
Pollutants, mechanisms, and skin cancer
-
Boffetta P, Nyberg F. Contribution of environmental factors to cancer risk. Br MedBull. 2003;68:71–94.https://doi.org/10.1093/bmb/ldg033 PubMed:https://pubmed.ncbi.nlm.nih.gov/12920177
-
Weidthak M, Schalekamp M, van der Meulen H,et al. Polycyclic aromatic hydrocarbons and skincarcinogenesis: mechanisms and riskassessment. Chemosphere. 2020;257:127170.https://doi.org/10.1016/j.chemosphere.2020.127170 PubMed:https://pubmed.ncbi.nlm.nih.gov/32000000
-
Nohmi T. DNA adducts and mutagenicity ofPAHs in skin. Mutat Res. 2016;769:29–40.https://doi.org/10.1016/j.mrfmmm.2016.06.003PubMed:https://pubmed.ncbi.nlm.nih.gov/27390591
-
Riva DR, Terada AM, de Oliveira Galvão M, et al.Air pollution and skin aging: role of oxidativestress and inflammation. Int J Environ Res PublicHealth. 2019;16(23):4480.https://doi.org/10.3390/ijerph16234480PubMed:https://pubmed.ncbi.nlm.nih.gov/31736616 PMC:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926975/
-
You J, Quan C, Li Z, et al. Ambient air pollutionexposure and non‑melanoma skin cancer risk:systematic review and meta‑analysis. EnvironRes. 2022;212:113195.https://doi.org/10.1016/j.envres.2022.113195PubMed:https://pubmed.ncbi.nlm.nih.gov/35113690
-
Barry V, Winquist A, Steenland K. PFOAexposures and cancer outcomes: systematicreview. Environ Health Perspect. 2013;121(7):881–890. https://doi.org/10.1289/ehp.1205826PubMed:https://pubmed.ncbi.nlm.nih.gov/23552439PMC:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702009/
-
Wang Z, DeWitt JC, Higgins CP, Cousins IT. PFASreview. Environ Sci Technol. 2017;51(5):2508–2518. https://doi.org/10.1021/acs.est.6b04806PubMed:https://pubmed.ncbi.nlm.nih.gov/28135054
-
Gore AC, Chappell VA, Fenton SE, et al. EDC‑2:Endocrine Society scientific statement onendocrine‑disrupting chemicals. Endocr Rev.2015;36(6):E1–E150.https://doi.org/10.1210/er.2015-1010 PubMed:https://pubmed.ncbi.nlm.nih.gov/26544515
-
Abernathy CO, Thomas DJ, Calderón RL.Arsenic: health effects, mechanisms, andresearch issues. Environ Health Perspect.1999;107(7):593–597.https://doi.org/10.1289/ehp.99107593 PubMed:https://pubmed.ncbi.nlm.nih.gov/10464062PMC:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1566279/
-
Lawrence BP, et al. Environmental toxicants andimmune dysfunction. Environ Health Perspect.2017;125(6):066002.https://doi.org/10.1289/EHP2646 PubMed:https://pubmed.ncbi.nlm.nih.gov/28502001
